Author Question: A nurse assesses a patient with chronic cancer pain who is receiving imipramine (Tofranil) in ... (Read 73 times)

corkyiscool3328 · **on:** Jun 25, 2018

A nurse assesses a patient with chronic cancer pain who is receiving imipramine (Tofranil) in addition to long-acting morphine. Which statement, if made by the patient, indicates to the nurse that the patient is receiving adequate pain control?

a. I'm not anxious at all.
b. I sleep 8 hours every night.
c. I feel much less depressed since I've been taking the Tofranil.
d. The pain is manageable and I can accomplish my desired activities.

Question 2

A patient who uses a fentanyl (Duragesic) patch for chronic cancer pain suddenly complains of rapid onset pain at a level 9 (0 to 10 scale) and requests something for pain that will work now.

How will the nurse document the type of pain reported by this patient?
a. Somatic pain
b. Referred pain
c. Neuropathic pain
d. Breakthrough pain

Viet Thy · **Reply #1 on:** Jun 25, 2018

Answer to Question 1

ANS: D
Imipramine is being used in this patient to manage chronic pain and improve functional ability. Although the medication is also prescribed for patients with depression, insomnia, and anxiety, the evaluation for this patient is based on improved pain control and activity level.

Answer to Question 2

ANS: D
Pain that occurs beyond the chronic pain already being treated by appropriate analgesics is termed breakthrough pain. Neuropathic pain is caused by damage to peripheral nerves or the central nervous system (CNS). Somatic pain is localized and arises from bone, joint, muscle, skin, or connective tissue. Referred pain is pain that is localized in uninjured tissue.